JPH0148886B2 - - Google Patents

Info

Publication number
JPH0148886B2
JPH0148886B2 JP56161679A JP16167981A JPH0148886B2 JP H0148886 B2 JPH0148886 B2 JP H0148886B2 JP 56161679 A JP56161679 A JP 56161679A JP 16167981 A JP16167981 A JP 16167981A JP H0148886 B2 JPH0148886 B2 JP H0148886B2
Authority
JP
Japan
Prior art keywords
small intestine
extract
solution
cells
proliferation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP56161679A
Other languages
Japanese (ja)
Other versions
JPS5862116A (en
Inventor
Naochika Takahashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Kasei Corp
Original Assignee
Mitsubishi Kasei Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Kasei Corp filed Critical Mitsubishi Kasei Corp
Priority to JP56161679A priority Critical patent/JPS5862116A/en
Publication of JPS5862116A publication Critical patent/JPS5862116A/en
Publication of JPH0148886B2 publication Critical patent/JPH0148886B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)

Description

【発明の詳細な説明】[Detailed description of the invention]

本発明は肝細胞の増殖促進物質に関する。 本発明者は、温血動物の腸粘膜より、肝細胞の
増殖を促進する物質を得るべき種々検討した結
果、本発明に到達した。すなわち、本発明の要旨
は、温血せきつい動物の腸粘膜を採取し、これを
カルシウムを実質的に含有しない塩類溶液で処理
してホモジネートを得、次いでこの上清を加熱
し、更に透析することにより取得される物質であ
つて、非透析性であり、ConA―セフアロースク
ロマトグラフイーにより溶出され、その溶出物の
SDS―ポリアクリルアミドゲルによる電気泳動図
は分子量約48000〜16000に3本のバンドを有し、
かつ肝細胞の増殖促進作用を有することを特徴と
する肝細胞の増殖促進物質にある。 以下、本発明を詳細に説明する。 本発明における温血せきつい動物としては、ラ
ツト、マウス、ニワトリ、ヤギ、ウシ、ウサギブ
タ、ウマ等が挙げられる。 これらの動物の腸粘膜の種類としては、小腸、
盲腸、十二脂腸、空腸、廻腸、大腸が挙げられる
が、通常、ウシ、ブタ、ニワトリ等の小腸、盲腸
が好適に使用される。 本発明に係る促進物質は、たとえば次のような
方法によつて得られる。 まず、上記動物の腸粘膜を採取する。採取は、
通常、擦過去により、腸上皮粘膜組織を得る。こ
れをカルシウムを実質的に含有しない塩類溶液で
処理してホモジネートを得る。これらの工程は通
常0〜2℃程度の温度で行なわれる。 上記塩類溶液としては、たとえばタイロード溶
液(Tyrode′s solution)(以下、「CMF」とい
う)が使用される。この溶液の組成は次のとおり
である。 NaCl 8.00 Na2HPO4 1.15 KCl 0.20 KE2PO4 0.20 (g/l) すなわち、塩類溶液としてはK,Na特にKを
含有するものが好適である。 カルシウムが含まれる溶液を使用すると、本発
明の所期の目的を達することができない。さらに
マグネシウムをも実質的に含有しない塩類溶液が
最も好ましい。すなわちカルシウム及びマグネシ
ウムを含有しないものが最適である。 次いでホモジネートから、遠心分離等により上
清を得る。遠心分離によるときは、通常8000〜
12000×gで数分以上で行なわれる。得られた上
清は加熱され、変性した高分子タンパタは沈殿除
去される。加熱は60〜100℃程度で行なわれる。
次いで上清を上記塩類溶液、たとえばCMFで透
析処理し、低分子量成分が除去される。 このようにして取得される物質は、次のような
性質を有する。 イ 良好な熱安定性を示し、非透析性である。 ロ ConA(コンカナバリンA)―セフアロース
クロマトグラフイーにより溶出される。すなわ
ち、多糖類又は糖タンパク質の性状を示さな
い。 ハ SDSポリアクリルアミドゲルによる電気泳動
図は分子量約48000〜16000に3本のバンドを有
する。 ニ 動物による種特異性を示さない。 ホ 肝細胞の増殖促進作用を有し、血清無添加培
地でもこの物質を添加することによつて肝実質
細胞の培養が可能である。 以上のように、本発明に係る物質は、肝機能促
進剤等としての適用が期待される。 以下、本発明を実施例により、さらに詳細に説
明するが、本発明はその要旨を超えないかぎり、
これら実施例に限定されるものではない。 実施例 1 生後約3ケ月のSprauge―Dawley系雄ラツト
の小腸粘膜抽出物を新生児ラツト肝細胞培養に添
加し、その増殖をみた。 (1) 小腸粘膜の採取及び抽出法 ラツトを軽くエーテル麻酔し、頚動脈を切断、
放血後、開腹して全小腸をとりだし、小腸内容物
をしぼり出し、冷CMF溶液で洗浄した。これを
手術用ハサミで縦に切り開き、ピンセツトで小腸
粘膜を擦過採取し、約10倍容のCMF溶液でホモ
ジネート後、12000×g、30分間遠心分離し、上
滑を小腸粘膜抽出物とした。 (2) 加熱および透析処理 得られた小腸粘膜抽出物を、100℃、2分間加
熱後、12000×g、20分間遠心分離し上清を、
CMF溶液で24時間透析した。 (3) 試験 基本培地としてEagle MEM(組成を表1に示
す)を使用して、再生肝手術(注1)又は再生肝
擬似手術(注2)をしたラツト(術後24時間後)
の加熱、透析した小腸粘膜抽出物(1.3mg
protein/ml)を10%添加した。結果を表2に示
す。 なお、新生児ラツト肝細胞培養方法及び細胞数
の測定方法は次のとおりである。 a 新生児ラツト肝細胞培養方法 生後6日目の新生児ラツト8〜10頭を断首、放
血し、70%エタノールで消毒後、無菌箱の中に入
れ、以後遠心分離以外はすべて無菌箱中で操作し
た。腹部をハサミで切開し、全肝臓をとりだし、
CMF溶液でよく洗浄し、カミソリの刃で約1mm
角の大きさに細切した。細切した肝臓を0.05%コ
ラーゲナーゼ(HanKs溶液に溶かしたもの。該
溶液の組成は、表3に示す)で37℃、1時間イン
キユベートし、その後二重のナイロンガーゼでろ
過し、CMF溶液で洗浄後、再度二重のナイロン
ガーゼでろ過した。ろ過した粗細胞浮遊液を40×
g、2分間低速遠心分離し、肝実質細胞を集め、
その上清を取り除き、ふたたびCMF溶液を加え、
軽くピペツテイングし、同様に遠心分離し、以下
同じ遠心操作を2回くり返し、細胞をよく洗浄し
た。 洗浄した細胞を目的とする培地にいれ、プラス
チツクシヤーレ(35×15mm)に各1.5c.c.ずつ細胞
をまき、37℃、95%air−5%CO2の気相で培養
した。 b 細胞数の測定方法 培養後、測定日にシヤーレをとり出し、培地を
取り除き0.25%トリプシン(CMF溶液に溶かし
たもの)で37℃、30分間インキユベートし細胞を
シヤーレよりはがした。その細胞浮遊液を500×
g、10分間遠心分離し、細胞を集めそれを既知量
のCMF溶液に溶かし、トリパンブルーで染色後、
肝実質の生細胞のみを、ヘマトメータにより測定
した(トリパンブルーの染色により、核の染まら
ないものを生細胞とした)。なお、各3個のシヤ
ーレを測定し、その平均値を細胞数とした。
The present invention relates to a substance that promotes proliferation of hepatocytes. The present inventor has arrived at the present invention as a result of various studies to obtain a substance that promotes the proliferation of hepatocytes from the intestinal mucosa of warm-blooded animals. That is, the gist of the present invention is to collect the intestinal mucosa of a warm-blooded cough animal, treat it with a saline solution that is substantially free of calcium to obtain a homogenate, and then heat the supernatant and further dialyze it. It is a non-dialyzable substance obtained by ConA-sepharose chromatography, and the eluate is
The electropherogram obtained by SDS-polyacrylamide gel has three bands with molecular weights of approximately 48,000 to 16,000.
The present invention is a hepatocyte proliferation promoting substance characterized by having a hepatocyte proliferation promoting effect. The present invention will be explained in detail below. Examples of warm-blooded animals in the present invention include rats, mice, chickens, goats, cows, rabbits, pigs, and horses. The types of intestinal mucosa in these animals include small intestine,
Examples include the cecum, duodenum, jejunum, stentum, and large intestine, but usually the small intestine and cecum of cows, pigs, chickens, etc. are preferably used. The promoting substance according to the present invention can be obtained, for example, by the following method. First, the intestinal mucosa of the above animal is collected. The collection is
Intestinal epithelial mucosal tissue is usually obtained by scraping. This is treated with a saline solution substantially free of calcium to obtain a homogenate. These steps are usually carried out at a temperature of about 0 to 2°C. As the above-mentioned salt solution, Tyrode's solution (hereinafter referred to as "CMF") is used, for example. The composition of this solution is as follows. NaCl 8.00 Na 2 HPO 4 1.15 KCl 0.20 KE 2 PO 4 0.20 (g/l) That is, as a salt solution, one containing K, Na, especially K is suitable. The intended purpose of the invention cannot be achieved if a solution containing calcium is used. Furthermore, a salt solution that does not substantially contain magnesium is most preferable. In other words, it is optimal to use one that does not contain calcium or magnesium. A supernatant is then obtained from the homogenate by centrifugation or the like. When using centrifugation, it is usually 8000 ~
The test is carried out at 12,000×g for several minutes or more. The obtained supernatant is heated, and the denatured polymeric protein is precipitated and removed. Heating is performed at about 60 to 100°C.
The supernatant is then dialyzed against the above-mentioned saline solution, such as CMF, to remove low molecular weight components. The substance obtained in this way has the following properties. B. Shows good thermal stability and is non-dialyzable. B ConA (concanavalin A) - eluted by sepharose chromatography. That is, it does not exhibit properties of polysaccharides or glycoproteins. C. The electropherogram obtained by SDS polyacrylamide gel has three bands with molecular weights of about 48,000 to 16,000. D. Does not exhibit species specificity depending on the animal. E) It has the effect of promoting proliferation of hepatocytes, and by adding this substance, it is possible to culture hepatic parenchymal cells even in a serum-free medium. As described above, the substance according to the present invention is expected to be applied as a liver function promoter and the like. Hereinafter, the present invention will be explained in more detail with reference to Examples.
The present invention is not limited to these examples. Example 1 An extract of the small intestine mucosa of a male Sprauge-Dawley rat approximately 3 months old was added to a neonatal rat hepatocyte culture, and its proliferation was observed. (1) Collection and extraction method of small intestine mucosa The rat was lightly anesthetized with ether, the carotid artery was cut, and the carotid artery was cut.
After exsanguination, the whole small intestine was removed through laparotomy, and the contents of the small intestine were expressed and washed with cold CMF solution. This was cut lengthwise with surgical scissors, the small intestine mucosa was scraped and collected with tweezers, homogenized with approximately 10 times the volume of CMF solution, centrifuged at 12,000 x g for 30 minutes, and the supernatant was used as a small intestine mucosal extract. (2) Heating and dialysis treatment The obtained small intestinal mucosal extract was heated at 100°C for 2 minutes, then centrifuged at 12,000 x g for 20 minutes, and the supernatant was
Dialysis was performed with CMF solution for 24 hours. (3) Test Rats that underwent regenerative liver surgery (Note 1) or regenerative liver sham surgery (Note 2) using Eagle MEM (composition shown in Table 1) as the basic medium (24 hours after surgery)
Heated, dialyzed small intestine mucosal extract (1.3mg
protein/ml) was added at 10%. The results are shown in Table 2. The method for culturing neonatal rat hepatocytes and the method for measuring cell number are as follows. a Neonatal rat hepatocyte culture method 8 to 10 newborn rats on the 6th day of life were decapitated, exsanguinated, sterilized with 70% ethanol, and placed in a sterile box. From then on, all operations except centrifugation were performed in the sterile box. did. The abdomen was incised with scissors and the entire liver was removed.
Wash thoroughly with CMF solution, and use a razor blade to remove approximately 1 mm.
Cut into square pieces. The minced liver was incubated with 0.05% collagenase (dissolved in HanKs solution; the composition of the solution is shown in Table 3) at 37°C for 1 hour, then filtered through double nylon gauze, and incubated with CMF solution. After washing, it was filtered again through double nylon gauze. Filtered crude cell suspension 40x
g, low-speed centrifugation for 2 minutes to collect hepatic parenchymal cells;
Remove the supernatant, add CMF solution again,
The cells were gently pipetted and centrifuged in the same manner, and the same centrifugation was repeated twice to thoroughly wash the cells. The washed cells were placed in the desired medium, and 1.5 cc of each cell was sown in a plastic jar (35 x 15 mm), and cultured at 37°C in a gas phase of 95% air and 5% CO 2 . b Method for measuring cell number After culturing, on the day of measurement, the petals were taken out, the medium was removed, and the cells were incubated with 0.25% trypsin (dissolved in CMF solution) at 37°C for 30 minutes, and the cells were peeled off from the petals. 500x the cell suspension
g, Centrifuge for 10 minutes, collect the cells, dissolve them in a known amount of CMF solution, and stain with trypan blue.
Only viable cells in the liver parenchyma were measured using a hematometer (those whose nuclei were not stained by trypan blue staining were considered viable cells). In addition, three shears were each measured, and the average value was taken as the cell number.

【表】【table】

【表】【table】

【表】 以下は、再生肝手術と同様に縫合、消毒した。【table】 The following parts were sutured and disinfected in the same way as in regenerative liver surgery.

【表】 すなわち、上記小腸粘膜抽出物の添加により、
新生児ラツトの培養肝細胞の顕著な増殖がみられ
る。
[Table] That is, by adding the above small intestine mucosal extract,
Significant proliferation of cultured hepatocytes from neonatal rats is observed.

【表】 実施例 2 小腸粘膜抽出物を成熟ラツトの肝細胞培養に添
加し、細胞の接着率、増殖、肝機能をみた(基本
培地:Eagle MEM。)。 培養に供試する動物は、生後約2ケ月の
Sprauge―Dawley系雄ラツトを使用した。 a 細胞数の測定 細胞数の測定は、実施例1と同様の方法で行な
つた。正常なラツトの加熱透析した小腸粘膜抽出
物(0.3mgprotein/ml)を10%添加し、正常ラツ
ト血清を10%添加した場合と比較した。結果を表
4に示す。
[Table] Example 2 A small intestine mucosal extract was added to a culture of adult rat hepatocytes, and cell adhesion rate, proliferation, and liver function were observed (basic medium: Eagle MEM). The animals used for culture are approximately 2 months old.
Male Sprauge-Dawley rats were used. a Measurement of cell number The cell number was measured in the same manner as in Example 1. 10% of heat-dialyzed small intestine mucosal extract (0.3 mg protein/ml) from normal rats was added and compared with 10% of normal rat serum. The results are shown in Table 4.

【表】 上記小腸粘膜抽出物を添加した培地では、7日
間ほぼ細胞数を維持するが、正常なラツト血清を
添加した培地では徐々に減少することがわかる。 b 細胞の接着率 正常なラツトの加熱透析した小腸粘膜抽出物
0.8mgprotein/mlを10%添加したものと0.3mg
protein/mlを10%添加したものを使用した。対
照として、正常ラツト血清を10%添加したもの
と、無添加のものを使用した。結果を表5に示
す。 なお、細胞数の接着率の測定方法は次のとおり
である。 すなわち、培養24時間後にシヤーレを取り出
し、培地を取り除きCMF溶液で洗浄後、0.25%
トリプシンで37℃、30分間インキユベートし、細
胞をはがし、トリパンブルーにて細胞数を測定し
た。最初に細胞をまいた数に対するシヤーレの底
に付着した細胞の百分率で示した。
[Table] It can be seen that in the medium to which the small intestine mucosal extract was added, the cell number was almost maintained for 7 days, but in the medium to which normal rat serum was added, it gradually decreased. b Cell adhesion rate Heat-dialyzed small intestinal mucosal extract from normal rats
0.8mg protein/ml with 10% addition and 0.3mg
A solution containing 10% protein/ml was used. As a control, one with 10% normal rat serum added and one with no addition were used. The results are shown in Table 5. The method for measuring the adhesion rate of cell numbers is as follows. That is, after 24 hours of culture, the shears were taken out, the medium was removed, and after washing with CMF solution, 0.25%
The cells were incubated with trypsin at 37°C for 30 minutes, the cells were peeled off, and the number of cells was measured using trypan blue. It is expressed as the percentage of cells attached to the bottom of the shear dish relative to the number of cells initially seeded.

【表】【table】

【表】 すなわち、上記小腸粘膜抽出物を添加した場合
には、有意に接着率が高まつた。 c 培地中のアミノ酸尿素、アンモニアの測定 正常ラツトの加熱透析した小腸粘膜抽出物を10
%含むEagle MEM培地で3日間培養した後、そ
の培地をCMF溶、Eagle MEMの各培地に交換
し、3,6,9時間、37℃で培養し、各培地中の
アミノ酸、尿素、アンモニアを測定した。結果を
表6に示す。 アミノ酸態窒素:ニンヒドリン発色法によ
る。 尿素態窒素:ジアセチルモノオキシム法を用
いた測定試薬による。 アンモニア態窒素:バーセロツト
(Berthelot)反応を用いた。
[Table] That is, when the above small intestine mucosal extract was added, the adhesion rate was significantly increased. c Measurement of the amino acids urea and ammonia in the medium.
After culturing for 3 days in Eagle MEM medium containing It was measured. The results are shown in Table 6. Amino acid nitrogen: Based on ninhydrin color method. Urea nitrogen: Based on the measurement reagent using the diacetyl monooxime method. Ammonia nitrogen: Berthelot reaction was used.

【表】【table】

【表】 すなわち、上記小腸粘膜抽出物を添加し培養し
たときの肝細胞の、窒素代謝における肝機能は、
MEMとCMF溶液の異なる培地条件により、ア
ミノ酸、尿素、アンモニアの生成が変化すること
から、充分な肝機能を保持していると思われる。 実施例 3 ヤギ、ウサギ、ニワトリの加熱透析した小腸粘
膜抽出物を培地に添加し、ラツト肝細胞につい
て、接着率、増殖をみた。 ヤギは約3才の雌のザーネン種、ウサギは約10
ケ月齢の雄のニユージーランドホワイト、ニワト
リは約2ケ月齢の雄の白色レグホーンを使用し
た。 a 成熟ラツト肝細胞の接着率 ヤギ、ウサギ、ニワトリの加熱透析した小腸粘
膜抽出物を、実施例1に記載された方法で得、こ
れを10%添加して行なつた(0.8mgprotein/ml)。
このときの成熟ラツト肝細胞のの培養24時後の接
着率を表7に示す。
[Table] In other words, the liver function in nitrogen metabolism of hepatocytes when cultured with the above small intestine mucosal extract added is as follows:
Since the production of amino acids, urea, and ammonia changes depending on the different medium conditions of MEM and CMF solutions, it seems that sufficient liver function is maintained. Example 3 Heat-dialyzed small intestinal mucosal extracts from goats, rabbits, and chickens were added to the culture medium, and the adhesion rate and proliferation of rat hepatocytes were observed. The goat is a female Saanen breed, about 3 years old, and the rabbit is about 10 years old.
A male New Zealand White, approximately 2 months old, was used as the chicken; a white Leghorn male, approximately 2 months old, was used as the chicken. a Adhesion rate of mature rat hepatocytes Heat-dialyzed small intestinal mucosal extracts of goats, rabbits, and chickens were obtained by the method described in Example 1, and 10% of this was added (0.8 mg protein/ml). .
Table 7 shows the adhesion rate of the mature rat hepatocytes after 24 hours of culture.

【表】 b 新生児ラツト肝細胞の細胞数 ヤギ、ウサギ、ニワトリの加熱透析した小腸粘
膜抽出物(0.4mgprotein/ml)を10%添加した。
結果を表8に示す。
[Table] b Number of neonatal rat hepatocytes 10% heat-dialyzed small intestine mucosal extract (0.4 mg protein/ml) of goat, rabbit, and chicken was added.
The results are shown in Table 8.

【表】 実施例 4 a 加熱透析した正常ラツト小腸粘膜抽出物を
ConA―セフアロースクロマトグラフイーによ
り精製した。すなわち0.5M―NaCl―10mM
Tris―HClバツフアーPH7.5で、平衡にしたの
ち、上記抽出物を添加し、上記バツフアーで10
ml/hrの速さで溶出した。溶出パターンを図1
に示す。溶出された分画は一つであつた。 b この溶出された分画をコロジオンバツクにて
濃縮し、新生児ラツト肝細胞培養の培地に添加
し、5日間培養しその時の増殖をみたところ、
顕著な増殖がみられた(図2)。図2において、
―●―は溶出前の抽出物(0.04mg/ml)添加、
―〇―は溶出された抽出物(0.04mg/ml)添加
を表わす。 c 溶出された小腸粘膜抽出物を、5.6%SDSポ
リアクリルアミドゲルにて、PH7.4、0.4Mトリ
ス―酢酸バツフアーにて泳動した。染色はクマ
シーブルーにて染色した。その電気泳動図は、
分子量約48000、16000に3本のバンドを有する
ものであつた。 実施例 5 加熱透析した正常ラツト小腸粘膜抽出物をシエ
フアデツクスクロマトグラフイーにより分画し、
フラクシヨンコレクターに得られた分画物を、
280nmでUV吸収スペクトルを測定した。結果を
図3に示す。
[Table] Example 4 a A normal rat small intestine mucosa extract subjected to heat dialysis was
Purified by ConA-Sepharose chromatography. i.e. 0.5M-NaCl-10mM
After equilibration with Tris-HCl buffer PH7.5, add the above extract, and
It eluted at a rate of ml/hr. Figure 1 shows the elution pattern.
Shown below. Only one fraction was eluted. b This eluted fraction was concentrated in a collodion bag, added to a culture medium for neonatal rat hepatocytes, cultured for 5 days, and observed for proliferation.
Remarkable proliferation was observed (Figure 2). In Figure 2,
-●- is the addition of extract (0.04mg/ml) before elution,
-〇- indicates addition of eluted extract (0.04 mg/ml). c The eluted small intestine mucosal extract was run on a 5.6% SDS polyacrylamide gel in 0.4M Tris-acetic acid buffer at pH 7.4. Staining was done with Coomassie blue. The electropherogram is
It had a molecular weight of about 48,000 and three bands at 16,000. Example 5 A heat-dialyzed normal rat small intestine mucosal extract was fractionated by Sheaf Detection chromatography.
The fraction obtained in the fraction collector is
UV absorption spectra were measured at 280 nm. The results are shown in Figure 3.

【図面の簡単な説明】[Brief explanation of drawings]

図1は、ConA―セフアロースクロマトグラフ
イーによる正常ラツトの加熱透析した小腸粘膜抽
出物の溶出区分を示し、図2は溶出区分を添加し
たときの新生児ラツト肝細胞の増殖を示す図であ
り、図3はシエフアデツクスクロマトグラフイー
による分画物のUV吸収スペクトルを示す。
FIG. 1 shows the elution fraction of heat-dialyzed small intestine mucosal extract of normal rats by ConA-sepharose chromatography, and FIG. 2 shows the proliferation of neonatal rat hepatocytes when the elution fraction was added. FIG. 3 shows the UV absorption spectrum of the fraction obtained by SiF chromatography.

Claims (1)

【特許請求の範囲】[Claims] 1 温血せきつい動物の腸粘膜を採取し、これを
カルシウムを実質的に含有しない塩類溶液で処理
してホモジネートを得、次いでこの上清を加熱
し、更に透析することにより取得される物質であ
つて、非透析性であり、ConA−セフアロースク
ロマトグラフイーにより溶出され、その溶出物の
SDS−ポリアクリルアミドゲルによる電気泳動図
は分子量約48000〜16000に3本のバンドを有し、
かつ肝細胞の増殖促進作用を有することを特徴と
する肝細胞の増殖促進物質。
1. A substance obtained by collecting the intestinal mucosa of a warm-blooded coughing animal, treating it with a saline solution that does not substantially contain calcium to obtain a homogenate, then heating this supernatant, and further dialysis. It is non-dialyzable, eluted by ConA-Sepharose chromatography, and the eluate is
The electropherogram obtained by SDS-polyacrylamide gel has three bands with a molecular weight of approximately 48,000 to 16,000.
A hepatocyte proliferation-promoting substance characterized by having a hepatocyte proliferation-promoting effect.
JP56161679A 1981-10-09 1981-10-09 Multiplication promoting substance for hepatic cell Granted JPS5862116A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP56161679A JPS5862116A (en) 1981-10-09 1981-10-09 Multiplication promoting substance for hepatic cell

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56161679A JPS5862116A (en) 1981-10-09 1981-10-09 Multiplication promoting substance for hepatic cell

Publications (2)

Publication Number Publication Date
JPS5862116A JPS5862116A (en) 1983-04-13
JPH0148886B2 true JPH0148886B2 (en) 1989-10-20

Family

ID=15739776

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56161679A Granted JPS5862116A (en) 1981-10-09 1981-10-09 Multiplication promoting substance for hepatic cell

Country Status (1)

Country Link
JP (1) JPS5862116A (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60243019A (en) * 1984-05-17 1985-12-03 Mitsubishi Chem Ind Ltd Hepatic cell proliferation factor
US5328837A (en) * 1992-05-18 1994-07-12 Genentech, Inc. Hepatocyte growth factor protease domain variants
US5316921A (en) * 1992-05-18 1994-05-31 Genentech, Inc. Single-chain hepatocyte growth factor variants
EP0642580B1 (en) * 1992-05-18 2002-08-21 Genentech, Inc. Hepatocyte growth factor variants

Also Published As

Publication number Publication date
JPS5862116A (en) 1983-04-13

Similar Documents

Publication Publication Date Title
KR100977744B1 (en) Collagen and method for producing same
US5420248A (en) Unpigmented fish skin, particularly from flat fish, as a novel industrial source of collagen, extraction method, collagen and biomaterial thereby obtained
US5436135A (en) New preparation of placenta collagen, their extraction method and their applications
Sheela et al. In vitro degradation of radiolabelled, intact basement membrane mediated by cellular plasminogen activator
JPS59133276A (en) Manufacture of bonded collagen fiber sheet
JPH0148886B2 (en)
KR20060125995A (en) Process for preparing collagen from starfish
US5354269A (en) Method for treating cancer resections
JPS6253927A (en) Novel product of placenta collagen, extraction and application thereof
US5750378A (en) Method for preparing cellular fibronectin
CN101182358A (en) Purification method for preparing antler collagen
JPS62116519A (en) Cell metabolism activating substance extracted from placenta, extraction thereof and method for inactivating hepatitis virus
JPH0533206B2 (en)
RU2214827C1 (en) Method for preparing collagen for treatment of pathology of body tissues
JPS5959620A (en) Preparation of blood serum
KR101837118B1 (en) A Method for Extracting Collagen using Bacterial Fermentation
JPS61166393A (en) Culture of b lymphocyte and/or t lymphocyte
FI109766B (en) Process for preparing proteolytic mixture containing escharase
CN109810187A (en) A kind of extracting method and application of animal tendon tendon collagen
JPH04149200A (en) Collagen for cell culture substrate
JP2005312338A (en) Carrier for culturing cell
JPS63188699A (en) Cell growth promoting substance extracted from bovine mamma, extraction thereof and inactivation treatment of virus
JP2001112419A (en) Method for producing ii-type collagen
CA1206903A (en) Process for the preparation of a plasminogen activator
JPS63188698A (en) Cell growth promoting substance extracted from bovine thymus, extraction thereof and inactivation treatment of virus